Zdrowie i gospodarka · 12/01/2016
Next Generation Sequencing-Based Oncology Panels; Public Workshop; Request for Comments
The Food and Drug Administration (FDA) is announcing a public workshop entitled "Next Generation Sequencing-Based Oncology Panels." The purpose of this workshop is to obtain feedback on analytical and clinical validation approaches for next generation sequencing (NGS)- based oncology panels. Comments and suggestions generated through this workshop will help guide the development of appropriate regulatory standards for evaluation of NGS-based oncology panels in cancer patient management.